Canada Biotechnology & Medical Research

Thiogenesis Therapeutics Corp (TTI)

Track

Track

Ticker: TTI Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mullally, William Hogan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
256.06
Quantity 95,290 +20.6%
Value CA$4,950,699
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
276.89
Quantity 14,559 +18.1%
Value CA$1,821,761
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
431.41
Quantity 20,756 -33.3%
Value CA$1,321,002
3.5
Riggins, Brook Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.75
Quantity 50,000 +5.0%
Value CA$37,500
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.56
Quantity 4,000 +0.1%
Value CA$2,240
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.53
Quantity 12,000 +0.2%
Value CA$6,360
3.5
Riggins, Brook Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.44
Quantity 25,000 +2.6%
Value CA$11,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-01 2025-07-30 B Purchase
Mullally, William Hogan

Director of Issuer

Non-Executive Director
95,290 +20.6%
256.06
CA$4,950,699 		95,290 +20.6% 256.06 CA$4,950,699
2024-05-20 2024-02-05 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
14,559 +18.1%
276.89
CA$1,821,761 		14,559 +18.1% 276.89 CA$1,821,761
2024-05-20 2024-02-05 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
20,756 -33.3%
431.41
CA$1,321,002 		20,756 -33.3% 431.41 CA$1,321,002
2023-12-18 2023-12-15 B Purchase
3.5
Riggins, Brook

Director of Issuer, Senior Officer of Issuer

Executive Director
50,000 +5.0%
0.75
CA$37,500 		50,000 +5.0% 0.75 CA$37,500
2024-05-20 2023-03-31 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
4,000 +0.1%
0.56
CA$2,240 		4,000 +0.1% 0.56 CA$2,240
2024-05-20 2023-03-29 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
12,000 +0.2%
0.53
CA$6,360 		12,000 +0.2% 0.53 CA$6,360
2022-08-02 2022-08-02 B Purchase
3.5
Riggins, Brook

Director of Issuer, Senior Officer of Issuer

Executive Director
25,000 +2.6%
0.44
CA$11,000 		25,000 +2.6% 0.44 CA$11,000
Explore more

More insider trading research around Thiogenesis Therapeutics Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America